medigraphic.com
Instituto Nacional de Salud Pública

2003, Number S2

<< Back Next >>

salud publica mex 2003; 45 (S2)

Managing childhood lead poisoning

Markowitz ME

Language: Spanish
References: 12
Page: 225-231
PDF size: 90.05 Kb.


ABSTRACT

This paper reviews the clinical management of children with lead poisoning.A first step is to define the measures to be used in their assessment and be aware of the limitations. Measurements of blood lead levels can be made on anticoagulated whole blood samples using either: atomic absorption spectroscopy or anodic stripping voltametry. However a more accurate method is fluorescent RX'ray of the skeleton or systematic biochemical tests of lead levels in urine. Remedies include elimination of lead in the environment, changes in children's behavior and dietary checks for adequate calcium and iron intake.Chelation therapy, using Ca edetate and succimer eliminates lead from the skeleton, which is then quickly excleted using a cathartic to help prevent re-absorption. Chelation may save lives where BLLs are very high. There is usually a short term reduction of BLLs with a subsequent rise. Serious cases may require repeat therapies. Chelation should be considered in children with BLLs ›=45 µg/dl. Chelation therapy reduces BLLs and associated symptoms. However cognitive decline may be irreversible, indicating that emphasis should be on prevention rather than cure.


REFERENCES

  1. Centers for disease Control and Prevention. Preventing lead poisoning in young children: A statement by the Centers for Disease Control. Atlanta (GA): CDC, US. Dept. of Health and Human Services, 1991.

  2. Barry PSI. Distribution and storage of lead in human tissues. En: Nriagu JO, Ed. The biogeochemistry of lead in the environment amsterdam. Elsevier/North Holland Biomedical Press, 1978: 97-150.

  3. Rosen JF, Crocetti AF, Balbi K, Balbi J, Bailey C, Clemente I et al. Bone lead content assessed by L-line x-ray fluorescence in lead-exposed and non-lead exposed suburban populations in the United States. Proc Natl Acad Sci USA 1993;90: 2789-2792.

  4. Markowitz ME, Rosen JF. Need for the lead mobilization test in children with lead poisoning. J Pediatr 1991; 19:305-310.

  5. Rosen JF, Markowitz ME, Bijur PE, Jenks ST, Wielopolski L, Kalef-Ezra JA et al. L-line X-ray florescencse of cortical bone lead compared with the CaNa2EDTA test in lead-toxic children: Public health implications. Proc Natl Acad Sci USA 1989; 86:685-689.

  6. 6.Piomelli S. Free erythrocyte porphyrins in the detection of undue absorption of lead and iron deficiency. Clin Chem 1977;23:249-259.

  7. Rabinowitz MB, Wetherill GW, Kopple JD. Kinetic analysis of lead metabolism in healthy humans. J Clin Invest 1976;58:260-270.

  8. Markowitz ME, Rosen JF, Bijur PE. Effects of iron deficiency on lead metabolism in moderately lead toxic children. J Pediatr 1990;116: 360-364.

  9. Ruff HA, Markowitz ME, Kurtzberg D, Bijur PE, Rosen JF. Relationships among blood lead levels, iron deficiency, and cognitive development in two-year-old children. Environ Health Perspect 1996;104:180-185.

  10. Roan WJ, Dietrich KN, Ware JH, Dockery WD et al. The effect of chelation therapy with succimed on neuropsychological development in children exposed to lead. N Engl J Med 2001;344:1421-1426.

  11. Morris V, Markowitz ME, Rosen JF. Serial measurements of aminolevulinic acid dehydratase in children with lead toxicity. J Pediatr 1988;112:916-919.

  12. Fatal pediatric lead poisoning –New Hampshine, 2000. MMWR Morb Mortal WKly Rep June 8 2001;50(22):457-459.




2020     |     www.medigraphic.com